Multicenter point-prevalence evaluation of the utilization and safety of drug therapies for COVID-19
暂无分享，去创建一个
L. Schulz | M. Postelnick | M. Badowski | K. Fong | N. Rhodes | W. Moore | S. Michienzi | P. Srinivas | J. Beardsley | C. M. Hale | A. Shah | A. Pallotta | A. Dairem | J. Borkowski | R. Polisetty | E. S. Spivek